Latigo Biotherapeutics, Inc. (LTGO)

Latigo Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Latigo Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	10.86	6.67
Research & Development	-	99.53	56.78
Operating Expenses	-	110.39	63.45
Operating Income	-112.32	-110.39	-63.45
Interest Expense (Income)	-2.9	-2.94	-2.26
Other Expense (Income)	1.76	1.72	-0
Pretax Income	-111.18	-109.17	-61.18
Net Income	-111.18	-109.17	-61.18
Free Cash Flow	-103.5	-97.69	-51.03
EBITDA	-113.85	-111.86	-63.2
Depreciation & Amortization	0.23	0.25	0.24
EBIT	-114.08	-112.11	-63.45